Let’s play 'Who wants to be a CEO!'

Forbes compiled a list of a sensible, research-based career steps to land the top job, with tips to help in any industry, even for those who've set their sights high in the healthcare industry.

“The qualities a board looks for are really capabilities—and they can manifest themselves differently in different people. Inevitably the capabilities reflect a cluster of skills, knowledge and behaviors. Also, board decisions always involve trade-offs. No candidate is brilliant in everything, and committees will also consider how a candidate’s strengths complement the team he or she will work with. But the core five capabilities are still the basis of what they probe,” said Cathy Anterasian, Spencer Stuart’s Senior Partner and Practice Leader of CEO Succession in North America.

For the full story, click the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.